Showing results (11-20 of 15) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
European Journal of Nuclear Medicine and Molecular Imaging|March 6, 2021
2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development frameworkA Leuzy, N J Ashton, N Mattsson-Carlgren, et al.European Journal of Nuclear Medicine and Molecular Imaging|March 7, 2021
The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkersN J Ashton, A Leuzy, T K Karikari, et al.Nature Communications|December 3, 2017
Expressed fusion gene landscape and its impact in multiple myelomaA Cleynen, R Szalat, M Kemal Samur, et al.British Journal of Haematology|May 15, 2024
French early nationwide idecabtagene vicleucel chimeric antigen receptor T-cell therapy experience in patients with relapsed/refractory multiple myeloma (FENIX): A real-world IFM study from the DESCAR-T registryB Ferment, J Lambert, D Caillot, et al.Leukemia|July 30, 2013
Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patientsB Hebraud, X Leleu, V Lauwers-Cances, et al.Pageof 2